CClinicalTrials.gg
Sign In
Status unknownNCT01772433Updated Jan 21, 2013

Olive Oil Phonophoresis and Chronic Low Back

A Phase 2 interventional study of Olive oil and Phonophoresis gel in Low Back Pain, sponsored by Ardabil University of Medical Sciences. Status unknown at 1 site in Iran, Islamic Republic of. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2013-01-21.

Sponsored by Ardabil University of Medical Sciences · Phase 2, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jan 2013), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 2
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

This study is intended to evaluate the effect of olive oil phonophoresis on chronic law back pain in female athletes.

Read the detailed description

This study will enroll 60 female patients suffering from chronic low back pain. the study will run in single blind mode that only patients will kept unaware of treatment.

The duration of treatment is 10 days. patients will be assigned randomly to olive oil or placebo group. every day, they will take phonophoresis on lower back using phonophoresis gel as placebo or olive oil as treatment for 10 day. the questionnaires will be filled in baseline visit and day 10. any side effect of drugs or technique will be recorded

02

Conditions studied

  • Low Back Pain

Keywords

  • Low Back Pain
  • Topical Olive Oil
  • Phonophoresis
03

In context

Back Pain

2,373 studies on the registry are indexed under Back Pain; 284 are open to participants now.

This study's planned enrollment of 60 is close to the median of 60 across 1,941 interventional studies indexed under Back Pain.

Browse Back Pain studies →

Lead sponsor

Ardabil University of Medical Sciences is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Young female athletes suffering from low back pain for more than three months

Exclusion criteria

Exclusion Criteria:

  • Underlying systematic or visceral disease
  • Specific conditions such as neoplasm and fractures, spondylolisthesis
  • Previous low back surgery
  • Pregnancy
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (estimated)

Study arms

  • Placebo comparator
    Phonophoresis Gel

    The Phonophoresis gel will be used as placebo

    Drug: Phonophoresis gel

  • Experimental
    Olive Oil

    Olive oil will be used as a replacement to phonophoresis gel in this arm

    Dietary Supplement: Olive oil

Interventions

  • Dietary supplementOlive oil

    Phonophoresis with Olive oil for 10 day, daily

  • DrugPhonophoresis gel

    Phonophoresis with base gel for 10 days, daily

06

What researchers measure

Primary outcomes

  1. Pain Score

    Low back pain intensity will be measured using McGill questionnaire from 0 (no pain) to 10 (worst).

    Time frame: Change from Baseline in McGill Low Back Pain Scale at day 10

Secondary outcomes

  1. Physical function

    The ability of patients in doing daily activities will be measured using two qualified questionnaires

    Time frame: Change from Baseline in Phycical Function Scale at Day 10

Other outcomes

  1. Safety

    Any occurrence of drug induced side effects will be recorded

    Time frame: Day 10

07

Study locations

1 of 1 sites recruiting
  • Clinic of Physiotherpay
    Ardabil, 56197, Iran, Islamic Republic of
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 21, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01772433
Lead sponsor
Ardabil University of Medical Sciences
Collaborators
Islamic Azad University, Sanandaj
Responsible party
Shahab Bohlooli (Dr, Ardabil University of Medical Sciences) — Principal investigator
First posted
Jan 21, 2013
Start date
Jan 2013
Primary completion
Sep 2013 (estimated)
Completion
Oct 2013 (estimated)
Last update
Jan 21, 2013

Study contacts

Shahab Bohlooli, PhD
Contact
shahab.bohlooli@arums.ac.ir
Shahab Bohlooli, PhD
principal investigator · Department of Pharmacology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Back Pain→

Other studies from this sponsor

Ardabil University of Medical Sciences

Start the discussion